Ad is loading...
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
TEMRX
Price
$8.10
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
Ad is loading...

RNWFX vs TEMRX

Header iconRNWFX vs TEMRX Comparison
Open Charts RNWFX vs TEMRXBanner chart's image
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
Nuveen Emerging Markets Eq A
Price$8.10
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
RNWFX vs TEMRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWFX vs. TEMRX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWFX is a Buy and TEMRX is a Sell.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. TEMRX (1.67B). TEMRX pays higher dividends than RNWFX: TEMRX (2.89) vs RNWFX (1.51). RNWFX was incepted earlier than TEMRX: RNWFX (23 years) vs TEMRX (14 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. TEMRX (14.00). RNWFX has a lower initial minimum investment than TEMRX: RNWFX (250) vs TEMRX (2500). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. TEMRX (7.42). RNWFX return over 5 years is better than : 17.17 vs. TEMRX (-24.92).
RNWFXTEMRXRNWFX / TEMRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years14 years-
Gain YTD7.0991.631435%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets60.9B1.67B3,642%
Annual Yield % from dividends1.512.8952%
Returns for 1 year11.547.42156%
Returns for 3 years-14.55-29.3850%
Returns for 5 years17.17-24.92-69%
Returns for 10 years41.00-16.44-249%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics